Advertisement

Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis

  • Serena Pelusi
  • Federica Iuculano
  • Rosa Lombardi
  • Paolo Francione
  • Umberto Gianelli
  • Anna Ludovica Fracanzani
  • Silvia Fargion
IM - CASE RECORD

Case presentation

Dr. Iuculano, Dr. Pelusi, Dr. Lombardi, Dr. Francione

A 63-year-old woman regularly followed in our outpatient clinic and affected by hereditary hemochromatosis (HH), presented with sudden acute pain in the upper left abdominal quadrant.

The woman had been referred to our outpatient clinic several years before, at the age of 34, for the finding of elevated ferritin and circulating iron levels during hospitalization for acute hepatitis A. Elevation in iron parameters persisted even after hepatitis resolution.

Her previous medical history included a diagnosis of beta-thalassemia trait (hemoglobin levels 10–11 g/dl) and hysterectomy for menorrhagia at the age of 29. She had two full-term pregnancies, and had received iron therapy during those periods.

The family history was negative for hyperferritinemia. She reported 20 g ethanol consumption per day.

Her blood tests at first observation showed high levels in ferritin and transferrin saturation, lower end of normal...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human and animals performed by any of the authors.

Informed consent

Informed consent by the patient was obtained by the authors.

References

  1. 1.
    Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139(2):393–408CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Piperno et al (2000) Haemochromatosis in patients with beta-thalassaemia trait. Br J Haematol 111:908–914PubMedPubMedCentralGoogle Scholar
  3. 3.
    Fargion S, Sampietro M, Cappellini MD (2000) Thalassemias and their interactions with hemochromatosis. In: Barton JC, Edwards CQ (eds) hemochromatosis. Cambridge University Press, Cambridge, pp 435–441CrossRefGoogle Scholar
  4. 4.
    Martinez-Lopez J et al (2015) Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor. Ann Hematol 94:1237–1239CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Lopes da Silva R (2001) Coexistence of beta-thalassemia and polycythemia vera. Blood Cells Mol Dis 46(2):171–172CrossRefGoogle Scholar
  6. 6.
    Thomas JP (2001) β-Thalassemia minor and newly diagnosed polycythemia rubra vera in a 71-year-old woman. Hosp Physician 37:78–83Google Scholar
  7. 7.
    Langabeer SE (2017) Hemochromatosis, erythrocytosis and the JAK2 p.V617F mutation. J Int Fed Clin Chem Lab Med 28(1):92–93Google Scholar
  8. 8.
    Piccin A, Steurer M, Mitterer M, Blöchl EM et al (2015) Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia. Intern Emerg Med 10(4):451–460CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Barton JC, Bertoli LF, Acton RT (2004) HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer 4:6CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Andrikovics H, Meggyesi N, Szilvasi A, Tamaska A, Halm G, Lue S, Nahajevszky S, Egyed M, Varkonyi J, Mikala G, Sipos A, Kalasz L, Masszi T, Tordai A (2009) HFE C282Y mutation as a genetic modifier influencing disease suscepbility for chronic myeloproliferative disease. Cancer Epidemiol Biomarkers Prev 18:929–934CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Najean Y et al (1998) Epidemiological data in polycythaemia vera: a study of 842 cases. Hematol Cell Ther 40(4):159–165PubMedPubMedCentralGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna 2018

Authors and Affiliations

  • Serena Pelusi
    • 1
  • Federica Iuculano
    • 1
  • Rosa Lombardi
    • 1
  • Paolo Francione
    • 1
  • Umberto Gianelli
    • 2
  • Anna Ludovica Fracanzani
    • 1
  • Silvia Fargion
    • 1
  1. 1.Department of Pathophysiology and TransplantationUniversità degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  2. 2.Hematopathology Service, Pathology Unit, Department of Pathophysiology and TransplantationUniversità degli Studi di Milano, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore PoliclinicoMilanItaly

Personalised recommendations